Virometix AG

Showcase Sponsor

Virometix AG is a privately held biotechnology company developing a new generation of fully synthetic vaccines and immunotherapeutic drugs for the prevention and treatment of infectious diseases and cancer. Fast growing demands, health threats from newly arising complex viral and bacterial pathogens and increasingly stringent requirements for stability, safety and tolerability require new approaches to tackling current and future challenges. Rational molecular design, and Virometix' proprietary “Synthetic Virus-Like Particle” (SVLP) and “Synthetic Antigen Mimetics” (SAM) platforms allow for the rapid production and optimization of vaccine candidates with superior properties in terms of safety, efficacy and stability. Virometix is based in Zurich, Switzerland. 


Sign Up for Event Updates